DOUGLAS RICHARD - 29 Mar 2023 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Issuer symbol
MXCT
Transactions as of
29 Mar 2023
Net transactions value
+$345,480
Form type
4
Filing time
30 Mar 2023, 09:11:05 UTC
Previous filing
08 Jul 2022
Next filing
13 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Purchase $345,480 +80,000 +400% $4.32 100,000 29 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.